Caricamento...
Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT(1) Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice
Recent clinical trials have demonstrated that combination therapy with renin-angiotensin system inhibitors plus calcium channel blockers (CCBs) elicits beneficial effects on cardiovascular and renal events in hypertensive patients with high cardiovascular risks. In the present study, we hypothesized...
Salvato in:
| Autori principali: | , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Public Library of Science
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3858271/ https://ncbi.nlm.nih.gov/pubmed/24339994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0082082 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|